Valens Company Posts $18.8 Million In Q2 Revenue, Misses Consensus Estimates

Last night, The Valens Company (TSX: VLNS) reported its second quarter financial results. The firm posted net revenues of $18.8 million, a decline quarter over quarter, along with a net loss of $8.7 million for the three month period.

Revenues were down 6.2% on a quarter over quarter basis, with the company posting revenues of $18.8 million for the three month period as compared to $20.0 million in revenues for the prior period. Revenues also fell short of consensus estimates.

Gross profits were also down for the quarter, with the firm reporting gross profits of just $4.1 million for the quarter, as compared to $4.8 million in the previous quarter. Operating expenses meanwhile amounted to $15.0 million, with expenses lead by wages and salaries of $4.2 million, depreciation and amortization of $2.7 million, and professional fees of $2.3 million.

The firm posted a loss from operations of $10.8 million, leaving investors wondering what the path to profitability is at this point. Other income improved this loss slightly, driven by a foreign exchange gain of $0.4 million. After a $1.9 million provision for the recovery of income taxes, the firm posted a net loss of $8.7 million for the second quarter. In terms of adjusted EBITDA, the firm posted a loss of $5.0 million.

Looking to the balance sheet, the company saw its cash position decline significantly, with cash falling from $49.3 million to $23.9 million over the course of the quarter. Total current assets overall fell from $106.7 million to $93.0 million. Current liabilities meanwhile changed marginally, climbing from $29.0 million to $29.7 million.

The Valens Company last traded at $2.53 on the TSX.


Information for this briefing was found via Sedar and The Valens Company. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

Antimony Resources Expands New Discovery Following Trenching

Silver47 Kicks Off 7,000-Meter Drill Campaign at Nevada’s Hughes Project

Related News

Valens: Canaccord Lowers Price Target To $3.75

Earlier this month, The Valens Company (TSX: VLNS) reported their fiscal third-quarter financial results. The...

Sunday, October 31, 2021, 10:10:00 AM

Aurora Cannabis Begins Outsourcing Manufacturing With Initial Valens Company Agreement

Aurora Cannabis (TSX: ACB) appears to be in the process of changing its business model....

Thursday, October 28, 2021, 07:54:57 AM

Harvest Moon: Valens Company VS Medipharm Labs – Share Price Indicators

Of the 100 companies in the BI Global Cannabis Competitive Peers index tracked in 2019,...

Sunday, June 21, 2020, 05:00:00 PM

Valens: Analysts Reiterate Price Targets, Ratings Following Q3 Results

Last week, The Valens Company (TSX: VLNS) reported their third-quarter results. Revenues were stable quarter...

Tuesday, October 20, 2020, 12:19:00 PM

Valens: Haywood Reiterates Price Target, Raises Estimates

On June 1st, The Valens Company (TSX: VLNS) announced that they closed their C$40 million...

Sunday, June 6, 2021, 01:38:00 PM